Vetoquinol Launches Felpreva®, A New Three-Monthly Feline Spot-on Parasiticide
Vetoquinol is delighted to announce that Felpreva - the brand-new breakthrough in feline parasite protection - is now available for veterinarians to prescribe in the UK market. The announcement follows the marketing authorisation granted by the VMD in November 2021.
Felpreva is a long-awaited innovation in companion animal parasitology. It is the only spot-on parasiticide for cats to provide 3 months’ protection against fleas and ticks plus treatment against roundworms, tapeworms and ear mites all in a single dose. It is licensed for treatment of cats with, or at risk from, mixed parasitic infestations/infections. Felpreva is part of the endectocide class of veterinary parasiticides that covers both internal (endo) and external (ecto) parasites. It is a combination of active substances emodepside and praziquantel, with tigolaner, a novel bispyrazole active ingredient.
A recent survey revealed 43% of cat owners said that giving parasite protection to their cat makes them feel guilty, stressed, or worried. Felpreva provides an option to reduce the frequency of treatments, lessening stressful interactions between owners and their cats. With Felpreva’s convenience and longer-lasting flea and tick protection, it aims to help support compliance and thus improve the wellbeing of feline companions.
Helen Hunter, Senior Product Manager at Vetoquinol UK, said: “The launch of Felpreva is a truly proud moment for Vetoquinol, demonstrating our expertise, passion, and commitment to innovation in this essential category of companion animal medicine. It will allow us to safeguard the health of cats by bringing longer-lasting protection, convenience, and ease of use – for both pet owners and veterinary professionals. At a time when vets are treating more pets than ever before, the need for a breakthrough endectocide solution like Felpreva has never been greater.”
As a POM-V medication Felpreva is available exclusively via the vet channel and is in wholesalers now. For more information on Felpreva please contact your local Vetoquinol representative.
More from Vetoquinol
- Dr Duncan Lascelles to deliver webinar on switching NSAIDs
- Nearly two thirds of veterinary professionals say their mental health has declined since joining the profession
- Vetoquinol empowers the veterinary industry to battle burnout with three-part webinar series
- Vetoquinol UK achieves bronze accreditation with Investors in the Environment
- Vetoquinol Green Team drives long-term change